The overall goal of this project is to understand the molecular basis by which eukaryotic signal transduction networks are assembled. Interactions between most cytoplasmic signaling proteins are mediated by modular protein-protein recognition domains. We are focusing on several such domain families including SH3, PDZ, and L27 domains, because they play a central role organizing and """"""""wiring"""""""" individual proteins into pathways. In studying these domains, our general aims are: first, to understand their biophysical mechanisms of sequence-specific recognition; second, to exploit these mechanisms to develop novel strategies for inhibitor design; and third, to understand how these domains are used to assemble higher order signaling networks.
Our specific aims are to: 1) Continue developing a novel class peptoid inhibitors of SH3 and WW domains and to test these for effects in vivo 2) Determine the general rules of PDZ domain recognition by evaluating the energetic contribution of electrostatic, hydrogen bonding, and packing interactions. 3) Characterize the structure and mechanism of L27 domains, a novel family of hetero-oligomerization modulates involved in signaling complex assembly and targeting 4) Define the degree of signaling specificity encoded by individual SH3 domains in vivo, across the entire yeast proteome.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM055040-06
Application #
6624005
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Program Officer
Flicker, Paula F
Project Start
1997-01-01
Project End
2006-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
6
Fiscal Year
2003
Total Cost
$266,740
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Bugaj, L J; Sabnis, A J; Mitchell, A et al. (2018) Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway. Science 361:
Rupp, Levi J; Schumann, Kathrin; Roybal, Kole T et al. (2017) CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells. Sci Rep 7:737
Gordley, Russell M; Williams, Reid E; Bashor, Caleb J et al. (2016) Engineering dynamical control of cell fate switching using synthetic phospho-regulons. Proc Natl Acad Sci U S A 113:13528-13533
Roybal, Kole T; Rupp, Levi J; Morsut, Leonardo et al. (2016) Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits. Cell 164:770-9
Roybal, Kole T; Williams, Jasper Z; Morsut, Leonardo et al. (2016) Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell 167:419-432.e16
Gordley, Russell M; Bugaj, Lukasz J; Lim, Wendell A (2016) Modular engineering of cellular signaling proteins and networks. Curr Opin Struct Biol 39:106-114
Coyle, Scott M; Lim, Wendell A (2016) Mapping the functional versatility and fragility of Ras GTPase signaling circuits through in vitro network reconstitution. Elife 5:
Morsut, Leonardo; Roybal, Kole T; Xiong, Xin et al. (2016) Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors. Cell 164:780-91
Mitchell, Amir; Wei, Ping; Lim, Wendell A (2015) Oscillatory stress stimulation uncovers an Achilles' heel of the yeast MAPK signaling network. Science 350:1379-83
Wu, Chia-Yung; Roybal, Kole T; Puchner, Elias M et al. (2015) Remote control of therapeutic T cells through a small molecule-gated chimeric receptor. Science 350:aab4077

Showing the most recent 10 out of 42 publications